Sema4 Holdings Corp. (SMFR)

$0.8775

-0.03 (-3.25%)
Rating:
Recommendation:
-
Symbol SMFR
Price $0.8775
Beta 0.000
Volume Avg. 1.38M
Market Cap 334.013M
Shares () -
52 Week Range 0.83-9.18
1y Target Est -
DCF Unlevered SMFR DCF ->
DCF Levered SMFR LDCF ->
ROE -88.91% Strong Sell
ROA -32.28% Strong Sell
Operating Margin -
Debt / Equity 46.45% Neutral
P/E -
P/B 0.33 Neutral
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest SMFR news


Healthcare
Health Information Services
NASDAQ Global Select

Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services. It also offers Sema4 Signal that enables and advances precision oncology care, from prevention to treatment to remission; and testing for carrier screening, noninvasive prenatal testing, and newborn screening, as well as hereditary cancer testing. In addition, the company provides COVID-19 testing solutions. Sema4 Holdings Corp. was incorporated in 2020 and is headquartered in Stamford, Connecticut.